{"id":"https://openalex.org/A5072400531","orcid":null,"observed_orcids":[],"display_name":"Esslali Soukaina","raw_author_names":["Esslali Soukaina","Esslali, Soukaina","S. Esslali","Soukaina Esslali"],"full_name":"Esslali Soukaina","works_count":6,"cited_by_count":35,"summary_stats":{"2yr_mean_citedness":1.5,"h_index":3,"i10_index":2},"ids":{"openalex":"https://openalex.org/A5072400531","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210153608","ror":"https://ror.org/04cnscd67","display_name":"Universit\u00e9 Moulay Ismail de Meknes","country_code":"MA","type":"education","lineage":["https://openalex.org/I4210153608"]},"years":[2026,2024,2023]}],"last_known_institutions":[{"id":"https://openalex.org/I4210153608","ror":"https://ror.org/04cnscd67","display_name":"Universit\u00e9 Moulay Ismail de Meknes","country_code":"MA","type":"education","lineage":["https://openalex.org/I4210153608"]}],"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","count":6,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","count":3,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10002","display_name":"Advanced Chemical Physics Studies","count":1,"subfield":{"id":"https://openalex.org/subfields/3107","display_name":"Atomic and Molecular Physics, and Optics"},"field":{"id":"https://openalex.org/fields/31","display_name":"Physics and Astronomy"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","count":1,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","count":1,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12412","display_name":"Enzyme function and inhibition","value":1.86e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":1.68e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","value":1.48e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","value":1.47e-05,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13160","display_name":"Synthesis and Biological Evaluation","value":1.38e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.8516793251037598},{"id":"164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","score":0.8213671445846558},{"id":"21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","score":0.5230375528335571},{"id":"70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","score":0.4332753121852875},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.3384000062942505}],"counts_by_year":[{"year":2023,"works_count":2,"oa_works_count":1,"cited_by_count":3},{"year":2024,"works_count":2,"oa_works_count":1,"cited_by_count":9},{"year":2025,"works_count":1,"oa_works_count":1,"cited_by_count":14},{"year":2026,"works_count":1,"oa_works_count":0,"cited_by_count":9}],"display_name_alternatives":["Esslali Soukaina","Esslali, Soukaina","S. Esslali","Soukaina Esslali"],"block_key":"e soukaina","works_api_url":"https://api.openalex.org/works?filter=author.id:A5072400531","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5072400531","updated_date":"2026-11-10T14:30:39","created_date":"2023-02-25T00:00:00"}